מרצים אורחים

David Taggart

University of Oxford UK

Efraim Halevy

Former Director of Mossad Israel

Silvia G. Priori

Istituti Clinici Scientifici Maugeri SpA Italy

Biography

Silvia G. Priori, MD, PhD

Full Professor of Cardiology

University of Pavia- Italy

Director of Molecular Cardiology Unit

Istituti Clinici Scientifici Maugeri SpA & SB

Pavia – Italy

Director of Molecular Cardiology Unit

Centro Nacional de Investigaciones

Cardiovasculares Carlos III (CNIC) – Madrid – Spain

 

Silvia G Priori graduated in Medicine in 1985, became specialist in Cardiology in 1990 and got the PhD in Cardiac Pathophysiology in 1995. She is Full Professor of Cardiology at the University of Pavia, Director of General Medicine III Unit and of the Molecular Cardiology Laboratories at the ICS Maugeri and Director of the Cardiovascular Genetics Program, at the Carlos III (CNIC), Madrid.

Prof Priori was: Chairman Committee for ESC Practice Guidelines; President of the EHRA; Member of the ESC Board; Co-Chairman of the ESC Congress Programme Committee.

Prof Priori is now Vice-President of the ESC.

Her main research fields are Inherited Arrhythmias and Gene Therapy.

Giora Weisz

Columbia University Medical Center/NewYork Presbyterian Hospital USA

Biography

Dr. Weisz is an interventional cardiologist in NewYork-Presbyterian Columbia University Medical Center in New York city, and serves also as faculty of the Cardiovascular Research Foundation. Dr. Weisz graduated from the Hebrew University-Hadassah Medical School in Jerusalem, Israel. He completed his cardiology fellowship training at the Carmel Medical Center-Technion School of Medicine in Haifa, Israel, and underwent advanced training in interventional cardiology at Lenox Hill Hospital and the Cardiovascular Research Foundation in New York. Dr. Weisz is an internationally recognized researcher focused on innovative technologies in cardiovascular medicine. He has pioneered the use of robotic-enhanced coronary interventions, navigation and positioning technologies. Dr. Weisz has been the principal investigator for pivotal clinical studies leading to FDA approval of cutting-edge technologies in interventional cardiology, including device positioning and navigation and robotics.  He has been leading multicenter studies in interventional imaging, and the combination of PCI with pharmacological anti-ischemic treatment. Dr. Weisz has published extensively in the most prestigious peer-review medical journals.

Eldad Tzahor

Weizmann Institute of Science Israel

Biography

Prof. Eldad Tzahor received a BSc in biology from the Hebrew University of Jerusalem (1991), and a PhD in molecular biology (1999) at the Weizmann Institute of Science (Rehovot, Israel). After postdoctoral training at Harvard Medical School (Boston, USA), he joined the staff of the Weizmann Institute in 2003. Prof. Tzahor studies novel mechanisms for cardiac regeneration following injury in mammals, a major challenge in current biomedical research. The lab develops novel approaches in cardiac biology to stimulate heart regeneration and repair. Prof. Tzahor is considered a world leader in the field of cardiac regeneration. His research in the field of regenerative medicine could potentially lead to treatments for heart disease in adult patient. He is the recipient of a number of prestigious grants and awards, including two European Research Council (ERC) grants, Foundation LeDucq, Horizon 2020  Regenerative  Medicine and the Levinson Prize in Biology.

Prof. Tzahor is the father of Noam, Roy, and Yonatan. He swims and runs regularly, which he says are the best forms of exercise to reduce the risk of heart disease.

Alon Eisen

Rabin Medical Center Israel

Biography

Prof. Alon Eisen, Rabin Medical Center, Petah Tikva, Israel

Gregory Piazza

Brigham and Women’s Hospital USA

Biography

Dr. Piazza is Associate Professor of Medicine, Harvard Medical School and faculty in the Division of Cardiovascular Medicine at Brigham and Women's Hospital. Dr. Piazza received his medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts and completed residency in internal medicine, Chief Medical Residency, general cardiology fellowship, and an advanced cardiovascular imaging fellowship at the Beth Israel Deaconess Medical Center in Boston. He also completed a National Heart Lung and Blood Institute-sponsored advanced fellowship in vascular medicine at Brigham and Women’s Hospital.  Dr. Piazza’s research interests include the epidemiology, pathophysiology, diagnosis, treatment, and prevention of venous thromboembolism, thrombophilia-associated infertility, computerized decision support to improve cardiovascular outcomes, as well as stroke prevention in atrial fibrillation.

Harry J.G.M. Crijns

Maastricht UMC+ and Maastricht University The Netherlands

Biography

Professor and Chair of Cardiology

Department of Cardiology

Heart and Vascular Center and CARIM

Maastricht UMC+ and Maastricht University

The Netherlands

Graduated in medicine at the University of Amsterdam in 1981. He completed his cardiology training at the University Medical Center Groningen, The Netherlands in 1987, where he continued working as clinical cardiologist and electrophysiologist. He obtained a PhD at the University of Groningen in 1993 on Changes of Intracardiac Conduction Induced by Anti-arrhythmic Drugs – Importance of Use and Reverse Use-dependence. He served on several guidelines committees for atrial fibrillation. Contributions to the field of electrophysiology include improved rate/rhythm control (RACE-trials, HATCH score), stroke prevention (CHA2DS2-VASc) and bleeding in AF (HAS-BLED). Current interests: idiopathic AF, atherothrombotic mechanisms in AF progression; hybrid AF ablation; early rhythm control in high risk AF. He currently is Chair and professor of Cardiology and board member of the Cardiovascular Research Institute CARIM, Maastricht University.

Stephen Brecker

St George's Hospital, London UK

Biography

Professor Stephen Brecker is a Consultant Cardiologist at St George's Hospital, London and Professor of Cardiology at St Georges, University of London.  He has been Chief of Cardiology for the past five years.  His major research interest are focussed on improving safety and outcomes from transcatheter valvular interventions.

Eberhard Grube

University Hospital Bonn Germany

Biography

Eberhard Grube, MD, FACC, FACA, FSCAI

University Hospital Bonn, Germany

Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC) University Hospital Bonn, Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine.

He received his first degree in Medicine at the Rheinische Friedrich-Wilhelm-University in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School.

He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his post-doctoral lecturing qualification “Internal Medicine“ from the Rheinische Friedrich-Wilhelm-University in Bonn.

He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions.

His research interest includes drug eluting stents, distal protection devices, debulking devices, restenosis and in-stent restenosis.

Nir J. Uriel

Columbia University and Weill Cornell USA

Biography

Currently the director of New York Presbyterian Heart Failure, Heart Transplant and Mechanical Circulatory Support Programs and the director of those programs at Columbia University.

Nir J. Uriel is the past Chair of the Mechanical Circulatory Support Council of the International Society of Heart and Lung Transplantation (ISHLT, Chair 2017-2019, Past Chair 2019-2021). His contribution to scientific literature includes more than 240 peer-reviewed publications.  His research focus is on heart failure physiology, heart transplant and mechanical circulatory support. Nir studied the metabolic changes in advanced heart failure and the effect of LVAD therapy on metabolic profile of these patients, the above topic was the focus of my NIH K23 grant (1K23HL103795-01A1). During his K grant period he also completed MSc in Biostatics at the Mailman School of Public Health. A significant amount of Nir's research is devoted to mechanical circulatory support. He described the biological mechanisms of bleeding in heart failure patients supported by current generation LVADs, and was one of the first investigators to report the prevalence of acquired Type II von Willebrand’s disease in this patient population and the link to abnormal angiogenesis, he also developed and validated multiple algorithms for treatment of patients supported with mechanical assist devices: The ramp test for speed adjustment, hemodynamics management, aortic inefficiency assessment, ventricular tachyarrhythmia management and more. As a result of the above, Nir is currently the National Principal Investigator and the chairman for the medical working group for the MOMENTUM 3 study (The biggest study ever conducted in the field of MCS – 1028 LVAD patients, evaluating a new LVAD technology – HeartMate 3(HM 3), and an additional 1500 patients in the continued access program). The study was reported in the NEJM and led to the FDA approval of the device. Recently Nir was asked to serve as the part of the national principal investigators committee and steering committee for the next series of studies on HM 3 LVAD called the Study Group for the Elimination of Residual Risk with HM 3 (STARR HM 3). His research extends to heart transplantation and heart failure. Nir has received the Teaching Award at Columbia University and University of Chicago. He is committed to the training of the next generation of Clinical researcher in the field of cardiovascular medicine in general and heart failure in specific.

Judith S. Hochman

NYU Grossman School of Medicine USA

Biography

Judith Hochman, M.D., is Senior Associate Dean for Clinical Sciences, Co-Director of the NYU-HHC Clinical and Translational Science Institute, Harold Snyder Family Professor and Associate Director of the Leon Charney Division of Cardiology, and Director of the Cardiovascular Clinical Research Center at NYU Langone Health.
Dr. Hochman holds a Master’s Degree in Cellular and Developmental Biology from Harvard University and an MD from Harvard Medical School. She is an internationally recognized clinical trialist and expert in ischemic heart disease, having served as Study Chair for NHLBI-funded international clinical trials testing the role of revascularization for patients with ischemic heart disease, which led to two new recommendations regarding the role of revascularization (stents and coronary bypass surgery) in the US and International Practice Guidelines. She has served for over a decade on the NHLBI Board of External Experts, and on the American College of Cardiology (ACC)/ American Heart Association (AHA) Task Force on Practice Guidelines as well as guideline writing committees, the AHA Strategic Advisory Coordinating Committee and the FDA Cardiovascular and Renal Drugs Advisory Committee. She is Study Chair of the NHLBI-funded international ISCHEMIA comparative effectiveness trial testing two initial management strategies for patients with ischemia. The trial demonstrated no net difference in the primary outcome or all-cause mortality, but improved quality of life in those with baseline angina. The primary results of the trial have been presented at the AHA 2019 Scientific Sessions, published in the NEJM and widely covered with a billion media impressions. She was the inaugural director of the AHA-funded Sarah Ross Soter Center for Women’s Cardiovascular Research at NYU School of Medicine, where she and colleagues study myocardial infarction in women, with a focus on understanding why women more often than men have MI without typical blockages in their coronary arteries.
She has authored ~400 publications, reviews and chapters in major internal medicine and cardiovascular journals and textbooks. In addition, she was senior guest editor for Circulation and currently serves on the editorial boards of the Circulation, Journal of the American College of Cardiology, Journal of the American Medical Association Cardiology, the European Heart Journal and the American Heart Journal. Dr. Hochman has served as a mentor for numerous trainees who have gone on to have successful independent careers. She is the recipient of the 2008 AHA Women in Cardiology Mentoring Award, the 2014 Clinical Research Prize of the AHA, the 2016 Distinguished Scientist Award (Clinical Domain) of the ACC, the AHA 2018 James B. Herrick Award for Outstanding Achievement in Clinical Cardiology, and the invited presenter of the European Society of Cardiology 2020 Rene Laennec Lecture.

Jereon Bax מרצה אורח בכנס האיגוד הקרדיולוגי 2020

Jereon
Bax

Immediate Past President
European Society of Cardiology
The Netherlands

Robert Levine מרצה אורח בכנס האיגוד הקרדיולוגי 2020

Robert A. Levine

Harvard Medical School USA

William-J.-McKenna מרצה אורח בכנס האיגוד הקרדיולוגי 2020

William J. McKenna

University College London UK

Biography

William McKenna is Canadian (BA – Yale, MD – McGill). He is CEO & Medical Director, Heart Hospital, HMC. Previously he established the Inherited Cardiac Disease clinic at St George’s Hospital and then at the Heart Hospital – University College London. He is also Associate Dean for Research (Weill Cornell Medicine-Qatar), Emeritus Professor of Cardiology (UCL) & Adjunct Professor in CV Medicine (Yale). His main interests have been in clinical and basic research of the cardiomyopathies. His recent work has contributed to the identification of disease-causing genes in HCM, DCM and ARVC, to the establishment of new diagnostic criteria within the context of familial disease, and to the establishment of algorithms to identify patients at high risk of sudden death. He has published >500 research papers in peer review journals.

מרצים נוספים יעודכנו כאן בקרוב